Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme
about
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profileOverexpression of s6 kinase 1 in brain tumours is associated with induction of hypoxia-responsive genes and predicts patients' survivalNuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastomaThe proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motilityAnalysis of the regulation of fatty acid binding protein 7 expression in human renal carcinoma cell linesIdentification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaIdentification of noninvasive imaging surrogates for brain tumor gene-expression modulesIntegrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysComputational analysis of tissue-specific combinatorial gene regulation: predicting interaction between transcription factors in human tissuesId4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomasGenome-scale identification of membrane-associated human mRNAs.Adoptive cell therapies for glioblastomaBrain fatty acid binding protein (Fabp7) is diurnally regulated in astrocytes and hippocampal granule cell precursors in adult rodent brainThe p75 neurotrophin receptor is a central regulator of glioma invasionClustering cancer gene expression data: a comparative studyLoss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era.Phage display discovery of novel molecular targets in glioblastoma-initiating cellsDistinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcomeOlig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant gliomaIntegrated analysis of transcriptome in cancer patient-derived xenograftsCharacterization of microRNA expression profiles in normal human tissuesGenomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers.Modulation of HJURP (Holliday Junction-Recognizing Protein) levels is correlated with glioblastoma cells survivalB-FABP-expressing radial glial cells: the malignant glioma cell of origin?BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.A feature selection approach for identification of signature genes from SAGE data.Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data.Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysisDevelopment of a novel ozone- and photo-stable HyPer5 red fluorescent dye for array CGH and microarray gene expression analysis with consistent performance irrespective of environmental conditions.APRIL is overexpressed in cancer: link with tumor progressionA systems biology-based gene expression classifier of glioblastoma predicts survival with solid tumors.A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion.Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma.Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo.Clinical and molecular models of glioblastoma multiforme survivalMicroRNA-296-5p Promotes Invasiveness through Downregulation of Nerve Growth Factor Receptor and Caspase-8.Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence.Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells.
P2860
Q21245722-1E684D97-CDCB-4BB4-BCBE-C101570830B6Q21296638-44C32037-79C5-4117-A15F-532816349043Q24548280-694D267B-550D-4DAD-B9D9-2E649B4683B7Q24607682-EBDA9A3F-7053-47D3-86FF-4C9AA33B9193Q24611370-23FCB1B4-BFFC-464D-8D3A-257804A63864Q24612429-4A577C3A-70EF-4B08-A6C0-A1B6184745DAQ24647449-9E6AEBA4-618F-4F9D-B740-F06FB9A8497BQ24651548-CDD97625-F524-4FF9-9CCE-B9481C91061DQ24656128-A6C9BE36-9551-4609-8BE0-EB7BC785C260Q24674713-747A52A3-0DBF-40D9-8BA9-B3A2DAB959FBQ24816392-D2CDAED1-E337-4081-A0B0-B86951FE6112Q25256725-1CBD51D2-3AF1-4B12-AAA9-C01688F6A4D2Q27030863-BAE2BAFE-7A31-43A1-A4FC-663510B51B43Q27301892-A9D4508C-A39D-40B6-99C6-EC85953890FDQ27334481-ED37533D-D7B4-4599-A1CA-647BE0656EE9Q27496523-4DA40988-F121-4FE7-B4B5-1A5894704E4BQ27851755-56A9294E-778C-4FA5-9C4D-466BDBAD39EAQ28240138-788056BD-9622-4EFB-AEEA-AABC6AB6B5B0Q28273187-32F0ADBD-9A84-4AB0-84A9-3772BD6B1652Q28287898-A6CCBA14-B575-418A-9038-8514C3F443E8Q28547069-D87D202C-CC58-445C-9363-0FF3DCB6625CQ29615492-76F40E15-4AAB-4B8E-84F0-8D482C957783Q30414111-9BC3D58F-13DE-44E5-A82D-42511B0994C9Q30419684-EF0775B8-02EB-400B-B3A2-C9D2EEA3108DQ30480106-574D241E-DDA0-4E34-AE99-E92CFCF6D098Q30724766-B68BDBD2-5297-4A79-891A-D259D2FEF156Q30885944-3BD6487E-5DE0-4CB9-B520-8DDB3D2D29C3Q31113441-D5A75FD4-6D9E-44AC-9151-A66C531B667FQ31153954-331335D3-A35F-48F8-87E6-A1A0A7084FE6Q33370030-12A891C8-93AE-47B7-A2E7-593362D239E6Q33384863-106050CF-B6E2-4A88-9E35-560661F12283Q33418752-9319D4D7-7C61-4912-847C-4CED2F7B7C87Q33483366-78EF16A3-DC19-4756-BEEF-C102E1A326BBQ33546389-FD054DD7-C16E-4617-AAE1-B77399B6DF50Q33564214-EB505339-D718-4730-9D2A-3F34BF99C0A4Q33566796-13D95CFC-A95B-4A7B-8C2B-5EE74F267C96Q33601633-07A7C7F1-1F53-4C45-B675-D4C33290CB25Q33654642-B58D3039-05AA-4A06-8318-7C5F7E7F5161Q33664297-455DEDA7-D465-4FAF-95E6-32E5FD31F3F2Q33715154-65ED4F4C-F93F-46B5-BE9C-EC2BC4EF15A8
P2860
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Gene expression profiling reve ...... pes of glioblastoma multiforme
@ast
Gene expression profiling reve ...... pes of glioblastoma multiforme
@en
Gene expression profiling reve ...... pes of glioblastoma multiforme
@nl
type
label
Gene expression profiling reve ...... pes of glioblastoma multiforme
@ast
Gene expression profiling reve ...... pes of glioblastoma multiforme
@en
Gene expression profiling reve ...... pes of glioblastoma multiforme
@nl
prefLabel
Gene expression profiling reve ...... pes of glioblastoma multiforme
@ast
Gene expression profiling reve ...... pes of glioblastoma multiforme
@en
Gene expression profiling reve ...... pes of glioblastoma multiforme
@nl
P2093
P2860
P50
P3181
P356
P1476
Gene expression profiling reve ...... pes of glioblastoma multiforme
@en
P2093
Andrew W Bollen
Kathleen R Lamborn
Ken D Aldape
M Kelly Nicholas
Mark A Israel
Mitchel S Berger
P2860
P304
P3181
P356
10.1073/PNAS.0402870102
P407
P577
2005-04-19T00:00:00Z